Dupilumab leads to clinically relevant improvements in signs and symptoms of prurigo nodularis Presented ByProf. Gil Yosipovitch, University of Miami, FL, USA TrialPhase 2, LIBERTY-PN PRIME ConferenceEADV 2022 5 November, 2022 10:59
EADV 2022 Highlights Podcast Presented ByDr Rachel Giles, Medicom ConferenceEADV 2022 27 September, 2022 11:49